[May 07, 2013] Elite Pharmaceuticals is Among the Companies in the Pharmaceuticals Industry With the Lowest Current Ratio (ELTP, ECTE, NBS, PVCT, ENDP) Tweet May 07, 2013 (SmarTrend(R) News Watch via COMTEX) -- Below are the three companies in the Pharmaceuticals industry with the lowest current ratios. Current ratio is useful to get an idea of how quickly a company can repay its short-term liabilities with its short-term assets. The higher the current ratio, the more capable the company is of paying its obligations.Elite Pharmaceuticals ranks lowest with a a current ratio of 0.3. Following is Echo Therapeutics with a a current ratio of 0.3. Neostem ranks third lowest with a a current ratio of 0.9. Provectus Pharmaceuticals follows with a a current ratio of 1.0, and Endo Pharmaceuticals rounds out the bottom five with a a current ratio of 1.1. SmarTrend recommended that subscribers consider buying shares of Endo Pharmaceuticals on January 24th, 2013 as our technology indicated a new Uptrend was in progress when shares hit $28.23. Since that recommendation, shares of Endo Pharmaceuticals have risen 33.1%. We continue to monitor Endo Pharmaceuticals for any potential shift so investors can protect gains and will alert SmarTrend subscribers immediately. Write to Chip Brian at [email protected] --------------------------------------------------------------------------------------------- SmarTrend analyzes over 5,000 securities simultaneously throughout the trading day and provides its subscribers with trend change alerts in real time. To get a free trial of our trading calls and maximize your trading results, please visit http://www.MySmarTrend.com Get exclusive, actionable insight into how the market is expected to trend prior to market open with our free morning newsletter. Sign up at: http://www.MySmarTrend.com/signup [ Back To TMCnet.com's Homepage ]